Hepatotoxicity with antibody maytansinoid conjugates: A review of preclinical and clinical findings
Author:
Affiliation:
1. Novartis Pharmaceuticals Inc.; East Hanover NJ USA
2. MedImmune, AstraZeneca; Gaithersburg MD USA
3. Charles River Laboratories Inc.; Reno NV USA
Publisher
Wiley
Subject
Toxicology
Reference127 articles.
1. Amiri-Kordestani , L. Blumenthal , G. M. Xu , Q. C. Zhang , L. Tang , S. W. Ha , L. Cortazar , P. 2014 FDA approval: Ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer Clinical Cancer Research, 20 4436 4441 https://doi.org/10.1158/1078-0432.CCR-14-0012
2. Trastuzumab emtansine: First global approval;Ballantyne;Drugs,2013
3. Strategies and challenges for the next generation of antibody-drug conjugates. Nature Reviews;Beck;Drug Discovery,2017
4. Fourth World Antibody-Drug Conjugate Summit: February 29-March 1, 2012, Frankfurt, Germany;Beck;Monoclonal Antibodies,2012
5. 472 A phase I study of IMGN388, an antibody drug conjugate targeting av integrin, in patients with solid tumors;Bendell;EJC Supplements,2010
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Detailed resume of S-methyltransferases: Categories, structures, biological functions and research advancements in related pathophysiology and pharmacotherapy;Biochemical Pharmacology;2024-08
2. Liver and Gall Bladder;Haschek and Rousseaux' s Handbook of Toxicologic Pathology;2024
3. New insights into the anticancer therapeutic potential of maytansine and its derivatives;Biomedicine & Pharmacotherapy;2023-09
4. Use of Payload Binding Selectivity Enhancers to Improve Therapeutic Index of Maytansinoid–Antibody–Drug Conjugates;Molecular Cancer Therapeutics;2023-07-25
5. METTL7A (TMT1A) and METTL7B (TMT1B) Are Responsible for AlkylS-Thiol Methyl Transferase Activity in Liver;Drug Metabolism and Disposition;2023-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3